Background: The Drosophila archipelago gene (ago) encodes the specificity component of a ubiquitin ligase that targets the cyclin E and dMyc proteins for degradation. Its human ortholog, Fbw7, is commonly lost in cancers, suggesting that failure to degrade ago/Fbw7 targets drives excess tissue growth. Results: We find that ago loss induces hyperplasia of some organs but paradoxically reduces the size of the adult eye. This reflects a requirement for ago to restrict apoptotic activity of the rbf1/de2f1 pathway adjacent to the eye-specific morphogenetic furrow (MF): ago mutant cells display elevated de2f1 activity, express the prodeath dE2f1 targets hid and rpr, and undergo high rates of apoptosis. These phenotypes are dependent on rbf1, de2f1, hid, and the rbf1/de2f1 regulators cyclin E and dacapo but are independent of dp53. A transactivation-deficient de2f1 allele blocks MF-associated apoptosis of ago mutant cells but does not retard their clonal overgrowth, indicating that intact de2f1 function is required for the death but not overproliferation of ago cells. Epidermal growth factor receptor (EGFR) and wingless (wg) alleles also modify the ago apoptotic phenotype, indicating that these pathways may modulate the underlying sensitivity of ago mutant cells to apoptotic signals. Conclusions: These data show that ago loss requires a collaborating block in cell death to efficiently drive tissue overgrowth and that this conditional phenotype reflects a role for ago in restricting apoptotic output of the rbf1/de2f1 pathway. Moreover, the susceptibility of ago mutant cells to succumb to this apoptotic program appears to depend on local variations in extracellular signaling that could thus determine tissuespecific fates of ago mutant cells.
Introduction
Genetic screens in the fruit fly Drosophila melanogaster have identified many genes that restrict growth of developing tissues (reviewed in [1, 2] ). In some cases, orthologs of these Drosophila growth suppressor genes have subsequently been implicated as vertebrate tumor suppressors. One example is the archipelago (ago) gene, which was identified because ago mutations confer a growth advantage to imaginal disc cells [3] . ago encodes an F box/WD (tryptophan/aspartic acid) protein (Ago) that acts as the substrate adaptor for an Skp/Cullin/F box (SCF) E3 ubiquitin ligase. SCF-Ago targets the G1/S cell-cycle regulator cyclin E (CycE) and dMyc, the fly ortholog of the c-Myc proto-oncogene, for degradation in vivo [3, 4] . These proteins hyperaccumulate in ago mutant cells and drive balanced increases in rates of division and growth, producing enlarged clones composed of normally sized cells [4] . In addition to this mitotic role, ago also regulates hypoxia sensitivity and postmitotic morphogenesis of the tracheal system via degradation of the Trachealess transcription factor [5, 6] .
Fbw7, the human ago ortholog, is frequently mutated in a wide array of human tumor types, including those of endometrial, colorectal, and hematopoietic origin (reviewed in [7] ). Moreover, deletion of murine Fbw7 increases cancer incidence and collaborates with p53 mutations to promote epithelial carcinogenesis [8] . Growth suppression by Fbw7 is linked to defective degradation of SCF substrates including CycE, c-Myc, the Notch intracellular domain, c-Jun, sterol regulatory element-binding protein (SREBP), and mTor kinase (reviewed in [7, 9] ). Thus, ago and Fbw7 both behave as antigrowth genes in vivo, and this property derives in part from their role in the timely destruction of common oncogenic substrates like CycE and Myc.
Many Drosophila mutations that accelerate the rate of cell proliferation also increase the size of the corresponding adult organ. Such mutations affect various regulatory networks, including the Tsc/Tor, IGF/PI3K, Sav/Wts/Hpo, ras/EGFR, and Notch pathways (reviewed in [1, 2] ). Notably, ectopic expression of progrowth factors such as dMyc in larval discs also increases adult organ size [10] . It is therefore somewhat surprising that adult eyes composed mainly of ago mutant cells expressing very high levels of dMyc are not obviously enlarged [3, 4] . One explanation for this might be that excess dMyc causes ago cells to behave as ''supercompetitors'' that kill adjacent normal cells [11, 12] , thus balancing the overall rate of growth of a mosaic organ. Alternately, an as yet unrecognized cell-autonomous mechanism might limit the ability of ago mutant cells to give rise to an enlarged organ.
Here, we uncover a requirement for ago to maintain eye size that reflects a cell-autonomous role for ago upstream of the rbf1/de2f1 pathway in cells just anterior to the eye-specific morphogenetic furrow (MF). ago mutant cells fail to downregulate de2f1-dependent transcription, express elevated levels of prodeath dE2f1 target genes, and undergo high rates of apoptosis. Blocking this death causes ago mutant discs to grow into enlarged adult eyes, indicating that ago loss requires a collaborating antiapoptotic event to drive eye hypertrophy. ago apoptotic phenotypes are also sensitive to EGFR and wingless signaling, indicating that extracellular pathways can alter the threshold for e2f1-driven death of ago mutant cells. These data identify ago as a required upstream regulator of the rbf1/ de2f1 pathway in eye disc cells and show that apoptosis mediated by this pathway can act as a significant brake on the growth of developing tissues lacking the ago tumor suppressor.
Results

Loss of ago Has Different Effects on the Size of Tissues in the Adult Head
Drosophila with eyes and heads composed almost entirely of ago mutant tissue were generated with the ago 1 allele and 1 encodes a prematurely truncated protein that cannot bind CycE and dMyc and increases levels of these proteins in vivo [3, 4] . Thus, the ago 1 /M(3) genotype provides a model of organ development in the absence of normal ago activity. Adult ago 1 / M(3) eyes were smaller than control eyes ( Figures 1A and  1B ). This phenotype was specific to the eye: other organs in ago 1 /M(3) heads, such as the antennae (arrows, Figures 1A and 1B) and interocular cuticle, grew larger. A similar effect was observed with other ago alleles (data not shown). Thus, although ago behaves as a growth suppressor in some tissues, it is required for the developing eye to reach its normal size.
Eye development is uniquely dependent on the MF, a moving compartment boundary that sweeps posterior to anterior across the larval disc and separates it into areas: asynchronously dividing cells anterior to the MF, G1 phase-arrested cells within the MF, and largely postmitotic cells posterior to the MF [14] . ago loss did not substantially alter the pattern of S phase entry in the vicinity of the MF (see Figure S1 available online), but it did produce an intense ''stripe'' of apoptosis, as detected with an antibody to the cleaved form of caspase-3 (C3), that extended laterally across the entire third-instar eye disc ( Figures 1C and 1D) . A second ago allele, ago 3 [3] , produced a similar pattern of apoptosis ( Figure S2 ). Costaining for C3 and Atonal protein, which marks cells within the MF [15] [16] [17] , showed that this death extended w5-10 cell diameters from the anterior edge of the MF into the anterior portion of the disc ( Figure 1E ). This pattern was strongest at the lateral margins of ago 1 /M(3) eye discs but was still penetrant enough to appear as a contiguous stripe in medial areas. Notably, C3 was also detected in ago 1 clones that crossed the MF (see below), indicating that this apoptosis is autonomous to ago cells and not a product of the cell-lethal technique used to generate ago 1 /M(3) discs. Thus, in addition to its growth suppressor function, ago is also required to protect cells from death in a region just anterior to the MF.
Blocking Death Increases ago Mutant Eye Size
The C3 data suggest that the MF is preceded by an intense wave of cell death that culls many cells from developing ago 1 /M(3) eyes. To test whether blocking this could reverse the ago small-eye phenotype, the ago 1 allele was combined with the Df(3)H99 genomic deletion, which removes the proapoptotic genes rpr, grim, and hid [18] . This completely blocked the C3 stripe (compare Figures 2A 0 and 2B 0 ) and produced adult heads that were much larger than ago 1 /M(3) or H99/ M(3) heads (compare Figures 2A and 2B ). H99/M(3) heads were similar in size to control FRT80B/M(3) heads (see below and data not shown). Thus, the ago 1 and H99 mutations cooperatively increase organ size. This effect was apparent in other head organs as well (e.g., antennae in Figure 2 and Figure S3 ). Combining ago 1 and the hid 05014 allele [19] was also sufficient to block C3 accumulation and increase organ size ( Figures 2C  and 2C 0 ; Figure S3 ). Together, these data indicate that hid-and H99-dependent apoptosis of ago 1 mutant cells restrains the oncogenic effect of ago loss in multiple tissues and that in the larval eye, this death is concentrated in an area just anterior to the MF.
ago Mutations Elevate dE2f Activity in the Furrow ago MF-associated apoptosis resembles the pattern of death among cells lacking the Drosophila retinoblastoma (Rb) gene homolog rbf1 [20] , suggesting that these genes function within a common antiapoptotic pathway in cells just anterior to the MF. Like mammalian Rb, Rbf1 binds to the dE2f1 transcription factor and inhibits the expression of dE2f1 target genes (reviewed in [21] ). This inhibition is reversed by G1 cyclin-dependent kinases that phosphorylate Rbf1 and dissociate it from dE2f1, allowing dE2f1 to transactivate target gene promoters. rbf1 mutations thus upregulate expression of dE2f1 targets, including PCNA [22] and the proapoptotic genes hid [23] and rpr [24] , which leads to MF-associated death of rbf1 mutant cells [20] .
To test whether ago controls de2f activity in the eye, we placed the dE2f reporter transgene PCNA-GFP [25] into the background of ago 1 mosaic eye discs ( Figure 3C ). dE2f1 protein levels normally increased in cells just anterior to the MF ( Figures 3A and 3A 0 ), presumably as a result of a requirement for dE2f1 in Rbf1-mediated transcriptional repression. Accordingly, expression of PCNA-GFP within the MF was low in wild-type areas of mosaic eye discs ( Figures 3C-3C 00 ; blue bracket denotes MF). By contrast, PCNA-GFP expression in ago 1 clones was elevated in the region just anterior to the MF (denoted by red bracket) and within the MF ( Figure 3C 0 ). The elevated PCNA-GFP expression just anterior to the MF appeared to correlate spatially with the location of C3 expression in ago 1 cells. RNAi depletion of ago also activated the dE2f-responsive reporter PCNA-luc in S2 cells ( Figure 3B ), although this was not associated with high rates of apoptosis (data not shown). The magnitude of the effect on PCNA-luc expression was less than that produced by directly targeting rbf1 with double-stranded RNA (dsRNA) interference, consistent with the idea that ago loss inactivates Rbf1 indirectly through intermediate factors. Because ago mutations do not change patterns of dE2f1 protein expression in discs (S.C.N. and K.H.M., unpublished data), they appear to derepress the existing pool of dE2f1 protein. Together, these observations indicate that ago mutations deprive cells of an important check on dE2f1 and suggest that this might activate an MF-associated apoptotic program similar to that elicited by loss of rbf1.
Because CycE hyperaccumulates in ago mutant cells throughout the eye disc [3] and acts upstream of de2f1 (reviewed in 21]), CycE-associated kinase activity might contribute to ago 1 MF-associated apoptosis. To test this hypothesis, we expressed the CycE/cdk2 inhibitor dacapo ubiquitously in ago 1 /M(3) discs. This reduced C3 staining ( Figures 3D  and 3E ), particularly toward the lateral edges of the disc. Reciprocally, expression of either cycE or dMyc in otherwise normal larval eye discs was able to induce ectopic apoptosis anterior to the MF ( Figure S4 ). Thus, elevated expression of two SCF-Ago targets is sufficient to elevate rates of apoptosis just anterior to the MF; moreover, the activity of one of these proteins, CycE, appears to be necessary for the ago MF-associated apoptotic phenotype.
de2f1 and rbf1 Control Apoptosis of ago Cells To directly test whether de2f1 is required for the MF-associated death of ago cells, we used the de2f1 i2 / rM729 viable allele combination to reduce de2f1 activity in the background of ago mosaic eye discs ( Figure 4 ). de2f1
rM729 is an amorph [26] , whereas de2f1 i2 is a hypomorph that lacks the activation domain and Rbf1-binding motif [27] . The de2f1 i2 / rM729 allele combination has no residual dE2f1 trans-activation function but supports normal patterns of division and MF progression in the eye disc [20] . MF-spanning ago clones accumulated high levels of C3 ( Figures 4A-4A 00 ) (as noted previously [3] , the ratio of mutant to normal tissue in the ago mosaic larval eye is less than that observed in the adult eye, indicating that the ago growth advantage arises progressively during eye development), but C3 was absent from ago 1 clones in the de2f1 i2/rM729 background (Figures 4B-4B 00 ). Residual C3 was sometimes detected in lateral areas of these discs (compare Figure 2B 0 and Figure 4B 0 ), suggesting that death of ago 1 cells in this area is not as dependent on de2f1 as it is in more central regions. Expression of rbf1 in ago 1 /M(3) discs was also able to substantially reduce the MF-associated C3 stripe ( Figure 5 ). Thus, reducing de2f1 activity, either by elevating levels of rbf1 or by removing the de2f1 trans-activation function, blocks death of ago 1 cells. Interestingly, although de2f1 i2/rM729 animals were proportionately smaller than de2f1 + animals, ago 1 mosaic eyes generated in the de2f1 i2/rM729 background showed a strong white:red ratio that was at least comparable to the white:red ratio of ago 1 mosaic eyes ( Figures 4C-4D 0 ). Thus, transactivation by dE2f1 is not required for the clonal growth advantage of ago 1 cells. Rather, the evidence suggests that the main effect of elevated de2f1 activity in ago 1 cells is to promote apoptosis, particularly in cells lying just anterior to the MF.
The somewhat paradoxical finding that expression of rbf1 might increase cell number by rescuing the death of ago 1 MF cells prompted a closer examination of the relationship between ago 1 eye size and gene dosage of G1/S regulatory factors. Eye size was determined by normalizing the twodimensional en face area of the eye to the area between the L3, L4, and posterior cross-veins ( Figure 6 ). This technique does not take into account bulging out of the surface of the eye and can underrepresent increases in eye size (e.g., ago 1 , hid 05014 /M(3) eyes were slightly larger than FRT80B/M(3) controls in an en face view [ Figure 6C ] but were much larger than FRT80B/M(3) in head-on views [ Figure S3] ). Nonetheless, we observed that heterozygosity for de2f1 significantly increased ago 1 /M(3) eye size ( Figures 6A-6C) . A similar effect is observed with a null allele of cyclin E (cycE AR95 ; [28] ). Thus, loss of ago creates a situation in which G1/S factors that normally promote the growth of wild-type organs become dosage-sensitive inhibitors of growth. Alleles of cdk4 (Figure 6C ) and dMyc (data not shown) also dominantly increased ago 1 /M(3) eye size but simultaneously increased adult wing size, so that the final eye:wing ratio was unchanged. Because de2f1 is required for apoptosis of ago 1 eye cells, these data are consistent with a model in which reducing the dose of de2f1 and cycE restores their activities to levels that are permissive for proliferation but reduce apoptosis. This phenomenon might be the invertebrate correlate of the ''E2F threshold'' hypothesis, in which the effect of E2F on cell number is postulated to depend on a hypothetical threshold of activity below which E2F promotes cell cycling and above which it becomes proapoptotic [29] .
Relationship between ago and Apoptotic Regulators E2F-driven cell death can occur by pathways that are either dependent on or independent of the p53 transcription factor (reviewed in [30] ). Expression of a dominant-negative form of Drosophila p53 (UAS-dp53 MF cells thus proceeds by dp53-independent mechanism that can be reversed by elevating expression of rbf1 or by removing the dE2f1 target gene hid. hid and rpr, which is also inducible by dE2f1 [24] , were both overexpressed in ago 1 /M(3) eye discs ( Figures 7A and 7B) , and Hid and Rpr proteins accumulated in ago 1 clones that overexpressed the antiapoptotic gene p35 ( Figures 7C-7D 00 ). This effect occurred anterior to the MF, but also in posterior areas of the eye disc. The MF-associated Hid accumulation seemed to be slightly more anterior relative to the MF than the C3 stripe, consistent with a delay between Hid expression and C3 buildup. Notably, not all ago 1 +p35 cells in the area anterior to the MF accumulated Hid and Rpr, indicating either that these proteins accumulate transiently in ago 1 cells even in the presence of p35 or that additional factors are limiting for their expression. Together, these molecular data indicate that ago 1 MF-associated apoptosis requires the de2f1 transactivation domain and transcription of the de2f1 targets hid and rpr.
The prosurvival activity of the epidermal growth factor receptor (EGFR) receptor tyrosine kinase (RTK) is linked in part to its ability to inhibit hid [32, 33] , and this function is proposed to underlie a prosurvival role for EGFR in rbf1 mutant MF cells [20] . Given that ago acts upstream of the de2f1 pathway and hid, we sought to determine whether the death of ago 1 cells also proceeds by an EGFR-sensitive mechanism. eyGal4-driven expression of the EGFR Ellipse gain-of-function allele (Elp) [34] blocked MF-associated C3 in ago 1 /M(3) discs ( Figures 8A and 8A 0 ) and synergized with ago 1 /M(3) to increase disc size ( Figure 8B ). Elav expression was normal in this genotype, indicating that C3 loss is not an indirect result of MF loss. C3 signal in posterior areas of ago 1 /M(3)+ey > Elp discs was also observed in ey > Elp discs (data not shown), indicating that it occurs independently of ago 1 . In the reciprocal experiment, EGFR activity was reduced in ago 1 /M(3) discs with the EGFR t1 hypomorphic allele [35] . This dramatically shrank ago 1 /M(3) adult eyes ( Figure 6C ). A similar effect was observed with a second allele, EGFR f24 (data not shown). These data indicate that ago 1 sensitizes eye cells to reduced EGFR signaling. To further test the interaction between EGFR/RTK signals and ago, C3 expression was tested in eye discs doubly mutant for ago and the EGFR inhibitors Gap1 (Gap1 F2.4-A3 ; K.H.M. and I.K. Hariharan, unpublished data) or argos (aos D7 ; [36] ) or the RTK inhibitor sprouty (sty D5 ; [37] ). Whereas each of these alleles is able to rescue rbf1 cell death in the MF [20] , they were not equally capable of rescuing the death of ago 1 MF cells ( Figures 8C-8E ): sty D5 largely blocked C3 accumulation, with two areas of C3 remaining laterally ( Figure 8C ), whereas neither Gap1 F2.4-A3 nor aos D7 detectably altered the pattern of C3 accumulation ( Figures 8D and 8E) . Because aos D7 rescues the death of rbf1 mutant MF cells [20] , these data argue that, although MF-associated apoptosis of ago 1 and rbf1 cells is similar in that they both require de2f1, ago 1 cells require stronger EGFR/RTK signals (i.e., sty D5 and ey > Elp) to survive than rbf1 mutant cells do. In support of this, sty D5 /M(3) eyes were larger than Gap1 F2.4-A3 /M(3) and aos D7 / M(3) eyes ( Figure 6C ), indicating that the sty D5 allele elicits stronger or more varied effects on downstream growth and survival pathways. Interestingly, compound loss of ago and sty, Gap1, or aos did not lead to a readily detectable increase in adult eye size beyond that observed with sty, Gap1, or aos alone ( Figure 6C ). Synergy in ago,Gap1 and ago,aos eyes might be obscured by MF-associated cell death. However, the lack of a synergistic effect between ago 1 and the sty
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allele might indicate that ago and sty regulate growth via overlapping mechanisms or that simultaneous loss of both genes activates other compensatory mechanisms that reduce final organ size. C3 expression at the lateral margins of ago 1 /M(3),ey > Elp eye discs resembles the expression pattern of the wingless (wg) morphogen, which plays a proapoptotic role at the margins of the late pupal eye disc [38, 39] . To test whether this lateral C3 might require wg, we placed one copy of the wg I-17 loss-of-function allele [40] in the ago 1 /M(3) background. This strongly reduced adult eye size ( Figure 6C ) and elevated rates of apoptosis among cells behind the MF (bracket in Figure 8F ). Thus, rather than engaging a Wg-dependent death pathway, ago 1 appears to sensitize cells to a Wg survival signal that operates among differentiated cells behind the MF. Together, these data argue that MF-associated death of ago 1 cells is driven by an autonomous mechanism requiring de2f1 but that the strength of this signal can be modified by signals transduced through the EGFR and RTK pathways. Moreover, a second pathway involving wg appears to modulate the sensitivity of ago 1 cells to death at a subsequent stage of development behind the MF. The net growth effects of ago mutations are thus a product of intrinsic proliferative properties and extrinsic signals that modulate rates of apoptosis among these cells.
Discussion
Many mammalian tumor suppressors simultaneously restrict cell proliferation and apoptosis. As a result, the oncogenic effect of inactivating these genes is balanced by increased apoptosis. Data presented here show that this central tenet of vertebrate cancer biology also applies to the Drosophila growth suppressor gene ago, a homolog of the mammalian tumor suppressor Fbw7. Eye overgrowth resulting from loss of ago is retarded by apoptosis that occurs as ago mutant cells encounter the MF. Blocking this death leads to eye hypertrophy, demonstrating that ago mutations can synergize with antiapoptotic mutations to drive organ overgrowth. The pattern of apoptosis in ago mutant eye discs resembles that caused by loss of the retinoblastoma homolog rbf1 [20] , and we find that ago acts as a required inhibitor of the de2f1/rbf1 pathway in this organ. Removing de2f1 trans-activation function from ago mutant cells blocks apoptosis but does not retard their clonal overgrowth, indicating that ago acts through de2f1 to activate transcription of genes required for apoptosis but not tissue growth. Together, these data link two tumor suppressor gene homologs, ago and rbf1, in a common developmental pathway and show that the role of ago as a required regulator of the rbf1/de2f1 pathway activity can have a significant impact on the phenotypic outcome of ago loss.
The tissue specificity of the ago apoptotic phenotype indicates that a signal associated with the MF provides a proapoptotic cue to ago cells. Because this signal, or combination of signals, is not known, it is difficult to predict where and when ago cells in other organs will die. Part of the prodeath stimulus may come from an inability of ago cells to respond to cell-cycle arrest pathways that begin to be activated as cells approach the MF. However, because cells in other organs (e.g., antennae) are also required to exit the cell cycle as part of their own differentiation programs, cell-cycle exit per se does not kill ago mutant cells. Thus, signals that are either eye specific or MF specific, or that are associated with sharply timed synchronous arrest (as in the zone of nonproliferating cells in the larval wing), may also play important roles in the death of ago cells.
rbf1 and ago mutant eye disc cells appear to share a common apoptotic mechanism that requires intact de2f1 function and involves elevated expression of prodeath genes like hid. However, the variable ability of EGFR pathway alleles to rescue death of ago and rbf1 mutant cells argues that ago loss may elicit a more complex and perhaps stronger proapoptotic stimulus than loss of rbf1. Because studies of rbf1-regulated apoptosis were performed with both hypomorphic (rbf1
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) and null (rbf1 14 ) alleles of rbf1 [20] , differences between ago and rbf1 mutant phenotypes are not easily attributable to differences in allele strength. We favor a model in which additional factors that act downstream of ago synergize with de2f1 to provide a prodeath stimulus that is stronger than that in rbf1 cells. de2f1 hyperactivation is still required for death in both situations, but because of these additional prodeath inputs, the threshold of EGFR/RTK signaling required to rescue ago cells is only met by the ey > Elp or sty D5 alleles. The reciprocal finding that an EGFR allele shrinks ago 1 /M(3) eyes supports a model in which EGFR signaling is limiting for the survival of ago cells and suggests that the fate of individual ago cells just anterior to the MF might depend on local variations in EGFR signaling strength in a manner similar to that shown for rbf1 cells [20] .
Based on studies showing that Fbw7 degrades the Notch intracellular domain [7] and that Notch-1 promotes the death of Fbw7 mutant mouse embryonic fibroblasts [41] , Notch is a candidate proapoptotic factor in ago cells. Indeed, because Notch is antagonistic to EGFR signaling (reviewed in [42] ), elevated Notch signaling is one potential explanation for the differential sensitivity of ago and rbf1 apoptosis to EGFR pathway alleles. Studies that place Drosophila Notch upstream of de2f in the larval eye disc [43] and within the MF [44, 45] suggest that it could synergize with CycE and dMyc to elevate de2f1 activity in ago cells. However, because CycE, dMyc, and Notch are all proposed to have de2f1-independent roles in cells, the differences between ago and rbf1 apoptotic phenotypes could involve roles for ago in pathways beyond the rbf1/de2f1 pathway.
In light of the high rates of apoptosis among ago 1 eye cells, it now appears that ago mutations were identified in mosaic screening only because the proliferative advantage conferred by ago loss could not be completely counterbalanced by increased death. A similar mechanism has been postulated to explain the relationship between ago loss and excess numbers of interommatidial cells in the pupal eye disc [3] . If this phenomenon can be generalized to other Drosophila antigrowth genes, then traditional mosaic screens carried out in the background of intact apoptotic signaling might be limited in their ability to identify factors that simultaneously restrict growth and apoptosis. Such genes might be more easily identified in screens designed to recover mutations that synergize with a block in apoptosis to drive hyperplasia.
The synergistic effect of ago and H99/hid loss on growth is quite similar to cooperativity between alleles of mammalian tumor suppressors like Rb and p53 (e.g., [46] ). Whether Fbw7 mutations require a collaborating block in death in order to promote vertebrate tumorigenesis has not been carefully examined. If so, then Drosophila may provide an excellent system in which to identify second-site modifiers of the ago small-eye phenotype whose vertebrate homologs are candidates to modulate the rate of growth of Fbw7 mutant tumors. Although some of these modifiers are expected to block apoptosis and reverse the ago small-eye phenotype (e.g., hid), others could increase apoptosis of ago 1 cells and shrink or ablate ago mutant organs (e.g., wg and EGFR). Thus, the fly eye may be an ideal system in which to identify genetic or pharmacological conditions that mimic conditions anterior to the MF and lead to widespread apoptosis of ago mutant cells. Such manipulations may be useful tools to induce the apoptotic death of human cancer cells lacking Fwb7 function. 
Eye Measurements
Eye and wings were photographed with a Leica DFC500 charge-coupled device digital camera, and sizes were quantitated with Adobe Photoshop. A minimum of ten eyes and wings were measured per genotype.
Immunohistochemistry and Microscopy
Immunostaining and confocal microscopy were performed as described previously [4] . Antibodies used were rabbit anti-cleaved caspase-3 (Cell Signaling, 1:100); rat anti-Elav (Developmental Studies Hybridoma Bank, 1:200); guinea pig anti-dE2f1 (T. Orr-Weaver, 1:1000); rabbit anti-GFP (Molecular Probes, 1:1000); mouse anti-b-gal (Promega, 1:1000); rabbit anti-Hid (H. Steller, 1:2500); rabbit anti-Reaper (S. Kornbluth, 1:1000). Scanning electron microscopy was performed by the Apkarian Integrated Electron Microscopy Core (Emory University) with a Topcon DS-130F field emission scanning electron microscope. Cell Culture S2 cells were cultured under standard conditions. dsRNA interference was carried out as described previously [47] . Reporter experiments were performed in triplicates in two separate experiments. Briefly, cells were pretreated with dsRNA for 4 days, transfected with PCNA-luc and pIE4-lacZ plasmids (Cellfectin, Invitrogen), and analyzed 48 hr later. Error bars represent the standard deviation of the mean.
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